Skip to content

AVS A-LAT PEEK SPACERS - 48753XXX

by Stryker Spine

510(k) K101051

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK101051 Date12 Aug 2010ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MAX
Models / Variants
48753XXX
Device Class
Class II
Regulation
21 CFR Part 888.3080
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 28 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The AVS A‑Lat Peek Spacers are intervertebral body fusion devices designed to be used with autogenous bone graft. They are intended for patients with degenerative disc disease at one level or two contiguous levels between L2 and S1, providing structural support to promote spinal fusion.

The spacers are supplied in four model sizes (48750XXX, 48751XXX, 48752XXX, 48753XXX) and were cleared by the FDA through a traditional 510(k) submission (K101051) as substantially equivalent to a predicate device. The clearance was granted on 12 August 2010 under product code MAX, and the devices are marketed by Stryker Spine in the United States.

Other devices from Stryker Spine

See all devices from Stryker Spine →

Questions

AI-generated answers, 28 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the intended use of the AVS A-LAT PEEK Spacers?

    The AVS A-LAT PEEK Spacers are intervertebral body fusion devices designed to provide structural support in the lumbar spine from L2 to S1 for patients with degenerative disc disease at one or two contiguous levels, promoting spinal fusion when used with autogenous bone graft.

  • How are the AVS A-LAT PEEK Spacers supplied and what models are available?

    The spacers are supplied in four distinct model sizes: 48750XXX, 48751XXX, 48752XXX, and 48753XXX, each corresponding to a specific footprint and height to accommodate varying patient anatomies and surgical needs during intervertebral fusion procedures.

  • Are the AVS A-LAT PEEK Spacers sterile and intended for single use?

    While the device data does not explicitly state sterility or single-use status, as intervertebral fusion implants, they are typically provided sterile and designed for single-use implantation; however, users should consult the product labeling for definitive instructions on handling, sterilization, and reuse limitations.

  • What regulatory pathway was used for the AVS A-LAT PEEK Spacers?

    The AVS A-LAT PEEK Spacers received FDA clearance through a traditional 510(k) submission (K101051), demonstrating substantial equivalence to a predicate device, with clearance granted on August 12, 2010, under product code MAX.